Airduo Respiclick Powder, Metered
NDC Package 59310-822-06
Package Information
Airduo Respiclick (fluticasone propionate and salmeterol) powders is aIRDUO® RESPICLICK® is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older. This formulation utilizes a powder, metered delivery system. Marketed by Teva Respiratory, Llc, this product is identified by NDC 59310-822 and is authorized under FDA application NDA208799.
Identification & Billing
- RxCUI: 1918194 - fluticasone propionate/salmeterol 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations
- RxCUI: 1918194 - 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler
- RxCUI: 1918194 - fluticasone propionate 113 MCG/ACTUAT / salmeterol xinafoate 14 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUATS
- RxCUI: 1918199 - AirDuo RespiClick 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations
- RxCUI: 1918199 - 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59310 - Teva Respiratory, Llc
- 59310-822 - Airduo Respiclick
- 59310-822-06 - 1 POUCH in 1 CARTON / 1 INHALER in 1 POUCH / 60 POWDER, METERED in 1 INHALER
- 59310-822 - Airduo Respiclick
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (59310-822). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59310-822-06 identifies a specific commercial package of 1 pouch in 1 carton / 1 inhaler in 1 pouch / 60 powder, metered in 1 inhaler of Airduo Respiclick, a human prescription drug labeled by Teva Respiratory, Llc. This powder, metered is formulated for respiratory (inhalation) use and contains fluticasone propionate; salmeterol xinafoate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Teva Respiratory, Llc on April 12, 2017. The current certification is valid through December 31, 2027.
How is this Teva Respiratory, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59310082206. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.